Oscar Health (NYSE:OSCR) CFO Sells $695,125.02 in Stock

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 31,683 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $695,125.02. Following the completion of the transaction, the chief financial officer owned 1,074,977 shares in the company, valued at approximately $23,584,995.38. This trade represents a 2.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Richard Scott Blackley also recently made the following trade(s):

• On Thursday, May 14th, Richard Scott Blackley sold 100,000 shares of Oscar Health stock. The stock was sold at an average price of $23.16, for a total transaction of $2,316,000.00.

Oscar Health Price Performance

Shares of OSCR stock traded up $3.04 during trading on Thursday, hitting $23.54. The company had a trading volume of 10,532,228 shares, compared to its average volume of 7,845,401. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The stock’s 50-day moving average is $17.92 and its two-hundred day moving average is $15.93. The stock has a market capitalization of $7.10 billion, a price-to-earnings ratio of -39.90, a price-to-earnings-growth ratio of 1.48 and a beta of 2.37. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $25.58.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.96. The company had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. Oscar Health’s revenue for the quarter was up 52.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.92 earnings per share. As a group, analysts predict that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of OSCR. Jones Financial Companies Lllp boosted its stake in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio bought a new position in shares of Oscar Health in the first quarter worth approximately $30,000. Fifth Third Bancorp grew its holdings in shares of Oscar Health by 148.7% in the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after purchasing an additional 1,413 shares during the last quarter. Quarry LP grew its holdings in shares of Oscar Health by 439.8% in the third quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after purchasing an additional 1,469 shares during the last quarter. Finally, Tsfg LLC bought a new position in shares of Oscar Health in the third quarter worth approximately $38,000. 75.70% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on OSCR. UBS Group increased their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Wolfe Research began coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating on the stock. Jefferies Financial Group upgraded shares of Oscar Health from an “underperform” rating to a “hold” rating and increased their price target for the company from $10.00 to $16.00 in a research report on Monday, April 20th. Barclays increased their price target on shares of Oscar Health from $21.00 to $30.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 26th. Finally, Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $20.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.